| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |